Clinical Trials for Highlight Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Highlight Therapeutics

Clinical Trials (3)

Clinical Trial to Evaluate BO-112 in Patients with Basal Cell Carcinoma (BCC)

PHASE2Recruiting

60 participants

Started: May 27, 2024 · Completed: Jun 30, 2028

1 condition1 sponsor10 locations

BO-112 With Pembrolizumab in Unresectable Malignant Melanoma

PHASE2Active, not recruiting

42 participants

Started: Dec 30, 2020 · Completed: Aug 1, 2024

1 condition2 sponsors19 locations

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

PHASE1Active, not recruiting

14 participants

Started: Oct 14, 2020 · Completed: Jan 31, 2027

30 conditions3 sponsors1 location